TY  - GEN
AU  - Napieralski,Rudolf
AU  - Ott,Katja
AU  - Kremer,Markus
AU  - Specht,Katja
AU  - Vogelsang,Holger
AU  - Becker,Karen
AU  - Müller,Martina
AU  - Lordick,Florian
AU  - Fink,Ulrich
AU  - Rüdiger Siewert,Jörg
AU  - Höfler,Heinz
AU  - Keller,Gisela
TI  - Combined GADD45A and thymidine phosphorylase expression levels predict response and survival of neoadjuvant-treated gastric cancer patients
SN  - 1078-0432
PY  - 2005///0829
KW  - Adult
KW  - Aged
KW  - Antigens, Nuclear
KW  - genetics
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Cell Cycle Proteins
KW  - Cisplatin
KW  - administration & dosage
KW  - DNA-Binding Proteins
KW  - Dihydrouracil Dehydrogenase (NADP)
KW  - Endonucleases
KW  - Female
KW  - Fluorouracil
KW  - Gene Expression Regulation, Neoplastic
KW  - drug effects
KW  - Humans
KW  - Ku Autoantigen
KW  - Male
KW  - Middle Aged
KW  - Neoadjuvant Therapy
KW  - Nuclear Proteins
KW  - Predictive Value of Tests
KW  - Prognosis
KW  - RNA, Messenger
KW  - Reverse Transcriptase Polymerase Chain Reaction
KW  - methods
KW  - Stomach Neoplasms
KW  - drug therapy
KW  - Survival Analysis
KW  - Thymidine Phosphorylase
KW  - Thymidylate Synthase
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial; Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1158/1078-0432.CCR-04-1605
ER  -